Related Experiment Video
Updated: Jun 13, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Paracorporeal continuous-flow ventricular assist devices (cfVADs) for children less than 20 kg: Challenging the
Ryan R Davies1, Mehreen Iqbal2, Jodie Lantz-Thomason3
1Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, Dallas, Tex; Heart Center at Children's Health, Dallas, Tex.
Insights
Continuous-flow ventricular assist devices (cfVADs) in small children (<20kg) with heart failure show high success rates and low complication rates. This strategy challenges the use of pulsatile VADs in this vulnerable population.
Area of Science:
- Pediatric Cardiology
- Mechanical Circulatory Support
- Heart Failure Management
Background:
- Small children with heart failure face high mortality and complication risks with current VADs.
- They are the only group not routinely managed with continuous-flow VADs (cfVADs).
Purpose of the Study:
- To evaluate the clinical course and outcomes of an exclusive cfVAD strategy in pediatric heart failure patients.
- To assess the efficacy and safety of cfVADs in children weighing less than 20 kg.
Main Methods:
- Retrospective review of pediatric patients (<20 kg) supported with paracorporeal VADs (2017-2024).
- Stratification by univentricular vs. biventricular physiology.
- Assessment of serious adverse events, competing risks, and successful support (survival to transplant/180 days or alive on support).
Main Results:
- 63 patients received paracorporeal cfVADs; 34.9% had prior ECMO support.
- Successful support was achieved in 82.5% of patients (70% univentricular, 93.9% biventricular).
- Stroke occurred in 15.9% of patients; outcomes were similar in those <5 kg.
Conclusions:
- An all-cfVAD strategy, primarily paracorporeal, yields excellent outcomes in small pediatric heart failure patients (<20 kg).
- High successful support rates and low neurologic complication rates were observed.
- This approach should prompt a reevaluation of VAD selection in this population, favoring cfVADs over pulsatile devices.
Objectives:
Small children with heart failure are at high risk for waitlist mortality, experience high complication rates on ventricular assist devices (VADs), and remain the only population not routinely supported with continuous-flow ventricular assist devices (cfVADs). We sought to describe the clinical course and outcomes of an exclusively cfVAD strategy in the management of small children with heart failure.
Methods:
This was a retrospective review of all patients less than 20 kg supported on paracorporeal VADs at a single institution (2017-2024), stratified by univentricular versus biventricular physiology pre-VAD. Outcomes after VAD implantation, including Advanced Cardiac Therapies Improving Outcomes Network-defined serious adverse events, competing risks, and successful support (survival to transplant or 180 days of support, or alive on support at study end), were assessed.
Results:
Sixty-three patients were supported on paracorporeal cfVADs. Presupport extracorporeal membrane oxygenation was common (22, 34.9%). Median days of support was 74 days (interquartile range, 32-133 days, maximum 811 days). Successful support was achieved in 52 (82.5%) patients (univentricular: 21 [70%]; biventricular: 31 [93.9%]; P = .01). Strokes occurred in 10 patients (15.9%) at a rate of 0.7 per patient-year of support. Outcomes were similar in patients less than 5 kg (n = 25, stroke: 16%, primary end-point success: 84.0%).
Conclusions:
An entirely cfVAD strategy, including predominantly paracorporeal cfVADs, in small patients less than 20 kg achieves excellent results, including high rates of successful support and low rates of hemorrhagic and neurologic complications. These results should challenge the current paradigm of using pulsatile VADs, especially in small patients.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation I: Indication and Settings
Acute Respiratory Failure-IV
Ventilatory Modes
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...

